TRAW

Traws Pharma, Inc.

Latest Form 4:Purchase$998KbyORBIMED ADVISORS LLC (10% Owner) · filed Apr 29, 2026

Traws Pharma, Inc. (TRAW) has 11 SEC Form 4 filings (11 transaction rows) in the rolling window, disclosed by 1 distinct insider. Most recent filing: Apr 29, 2026.

Insiders have net bought $998K over the trailing 6 months.

  • Industry:Biotechnology
  • CEO:Iain D. Dukes
  • Employees:7
  • HQ:Newtown, PA, US
  • IPO:2013-07-25

Insider Buying

$998K

reported purchases (SEC code P)

Insider Selling

$0

reported sales (SEC code S)

Unique Insiders

1

in the rolling window

Source
Purchase$998KApr 29SEC ↗

Related companies

Traws Pharma, Inc. is in the Healthcare sector.